The molecular principles of gene regulation by Polycomb repressive complexes

NP Blackledge, RJ Klose - Nature reviews Molecular cell biology, 2021 - nature.com
Precise control of gene expression is fundamental to cell function and development.
Although ultimately gene expression relies on DNA-binding transcription factors to guide the …

Polycomb gene silencing mechanisms: PRC2 chromatin targeting, H3K27me3'readout', and phase separation-based compaction

Y Guo, S Zhao, GG Wang - Trends in Genetics, 2021 - cell.com
Modulation of chromatin structure and/or modification by Polycomb repressive complexes
(PRCs) provides an important means to partition the genome into functionally distinct …

Epigenetic modifications affect the rate of spontaneous mutations in a pathogenic fungus

M Habig, C Lorrain, A Feurtey, J Komluski… - Nature …, 2021 - nature.com
Mutations are the source of genetic variation and the substrate for evolution. Genome-wide
mutation rates appear to be affected by selection and are probably adaptive. Mutation rates …

Going beyond Polycomb: EZH2 functions in prostate cancer

SH Park, KW Fong, E Mong, MC Martin, GE Schiltz… - Oncogene, 2021 - nature.com
Abstract The Polycomb group (PcG) protein Enhancer of Zeste Homolog 2 (EZH2) is one of
the three core subunits of the Polycomb Repressive Complex 2 (PRC2). It harbors histone …

The noncanonical role of EZH2 in cancer

J Huang, H Gou, J Yao, K Yi, Z Jin, M Matsuoka… - Cancer …, 2021 - Wiley Online Library
Enhancer of zeste homolog 2 (EZH2) is the catalytic subunit of polycomb repressive
complex 2 (PRC2). Dysregulation of EZH2 causes alteration of gene expression and …

Posttranslational regulation of FOXA1 by Polycomb and BUB3/USP7 deubiquitin complex in prostate cancer

SH Park, K Fong, J Kim, F Wang, X Lu, Y Lee… - Science …, 2021 - science.org
Forkhead box protein A1 (FOXA1) is essential for androgen-dependent prostate cancer
(PCa) growth. However, how FOXA1 levels are regulated remains elusive and its …

Polycomb repressive complex 2 modulation through the development of EZH2–EED interaction inhibitors and EED binders

S Tomassi, A Romanelli, C Zwergel… - Journal of Medicinal …, 2021 - ACS Publications
Epigenetics is nowadays a well-accepted area of research. In the last years, tremendous
progress was made regarding molecules targeting EZH2, directly or indirectly. Recently …

Non-histone protein methylation: biological significance and bioengineering potential

R Di Blasi, O Blyuss, JF Timms, D Conole… - ACS chemical …, 2021 - ACS Publications
Protein methylation is a key post-translational modification whose effects on gene
expression have been intensively studied over the last two decades. Recently, renewed …

Research progress of dual inhibitors targeting crosstalk between histone epigenetic modulators for cancer therapy

YC Duan, SJ Zhang, XJ Shi, LF Jin, T Yu… - European Journal of …, 2021 - Elsevier
Abnormal epigenetics is a critical hallmark of human cancers. Anticancer drug discovery
directed at histone epigenetic modulators has gained impressive advances with six drugs …

Noncanonical functions of the polycomb group protein EZH2 in breast cancer

T Anwar, ME Gonzalez, CG Kleer - The American Journal of Pathology, 2021 - Elsevier
Enhancer of Zeste Homologue 2 (EZH2) is the catalytic subunit of the polycomb repressive
complex 2 (PRC2) that is critical for determining cell identity. An epigenetic writer, EZH2 has …